S&P 500 Futures
(0.09%) 5 332.25 points
Dow Jones Futures
(0.02%) 40 145 points
Nasdaq Futures
(0.14%) 18 662 points
Oil
(-0.32%) $79.80
Gas
(0.57%) $2.64
Gold
(1.33%) $2 449.50
Silver
(3.01%) $32.20
Platinum
(0.31%) $1 093.40
USD/EUR
(0.04%) $0.920
USD/NOK
(0.01%) $10.68
USD/GBP
(0.04%) $0.787
USD/RUB
(-0.33%) $90.67

Realtime updates for BioPharma Credit PLC [BPCR.L]

Exchange: LSE Industry: Diversified Financials
Last Updated20 May 2024 @ 05:10

-0.27% $ 0.876

Live Chart Being Loaded With Signals

Commentary (20 May 2024 @ 05:10):
Profile picture for BioPharma Credit PLC

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its assets are secured by royalties or other cash flows derived from the sales of approved life sciences products...

Stats
Today's Volume 725 537
Average Volume 1.83M
Market Cap 10.67M
EPS $0 ( 2024-03-27 )
Next earnings date ( $0 ) 2024-06-12
Last Dividend $0.0175 ( 2023-08-17 )
Next Dividend $0 ( N/A )
P/E 10.95
ATR14 $0.00100 (0.11%)

BioPharma Credit PLC Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

BioPharma Credit PLC Financials

Annual 2023
Revenue: $110.49M
Gross Profit: $110.49M (100.00 %)
EPS: $0.0828
FY 2023
Revenue: $110.49M
Gross Profit: $110.49M (100.00 %)
EPS: $0.0828
FY 2022
Revenue: $184.25M
Gross Profit: $184.25M (100.00 %)
EPS: $0.130
FY 2021
Revenue: $87.97M
Gross Profit: $0.00 (0.00 %)
EPS: $0.0620

Financial Reports:

No articles found.

BioPharma Credit PLC Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0.0175
(N/A)
$0.0450
(N/A)
$0.0158
(N/A)
$0.0175
(N/A)
$0.0175
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

BioPharma Credit PLC Dividend Information - Dividend Knight

Dividend Sustainability Score: 7.79 - good (77.86%) | Divividend Growth Potential Score: 5.72 - Stable (14.32%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend $0.0100 2017-09-28
Last Dividend $0.0175 2023-08-17
Next Dividend $0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 25 --
Total Paid Out $0.385 --
Avg. Dividend % Per Year 1.46% --
Score 4.36 --
Div. Sustainability Score 7.79
Div.Growth Potential Score 5.72
Div. Directional Score 6.75 --
Next Divdend (Est)
(2024-07-01)
$0.0175 Estimate 21.90 %
Dividend Stability
0.58 Average
Dividend Score
4.36
Pay Frequency
Quarterly
Yearly Payout
Year Amount Yield
2017 $0.0200 0.02%
2018 $0.0594 0.06%
2019 $0.0543 0.05%
2020 $0.0479 0.05%
2021 $0.0554 0.06%
2022 $0.0975 0.10%
2023 $0.0508 5.35%
2024 $0 0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for LSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
PHAR.L Dividend Junior 2023-06-15 Sporadic 12 1.15%
FEVR.L Dividend Knight 2023-09-28 Semi-Annually 10 0.75%
TFIF.L Dividend Knight 2023-07-20 Quarterly 12 4.62%
KYGA.L Dividend Knight 2023-10-12 Semi-Annually 25 0.55%
CEY.L Dividend King 2023-08-31 Semi-Annually 11 3.71%
RESI.L Dividend Knight 2023-08-10 Quarterly 7 3.27%
GRG.L Dividend King 2023-09-07 Semi-Annually 32 1.71%
AJOT.L Dividend Knight 2023-10-05 Semi-Annually 5 0.68%
UPR.L Dividend Knight 2023-09-28 Annually 5 0.34%
MGCI.L Dividend King 2023-08-03 Quarterly 6 3.54%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.7991.50010.0010.00[0 - 0.5]
returnOnAssetsTTM0.07991.2007.348.80[0 - 0.3]
returnOnEquityTTM0.08131.500-0.208-0.312[0.1 - 1]
payoutRatioTTM0.828-1.0001.722-1.722[0 - 1]
currentRatioTTM9.790.80010.008.00[1 - 3]
quickRatioTTM9.780.80010.008.00[0.8 - 2.5]
cashRatioTTM8.511.50010.0010.00[0.2 - 2]
debtRatioTTM0-1.50000[0 - 0.6]
interestCoverageTTM01.000-1.111-1.111[3 - 30]
operatingCashFlowPerShareTTM0.09462.009.9710.00[0 - 30]
freeCashFlowPerShareTTM0.09462.009.9510.00[0 - 20]
debtEquityRatioTTM0-1.50000[0 - 2.5]
grossProfitMarginTTM1.0001.00010.0010.00[0.2 - 0.8]
operatingProfitMarginTTM0.7991.00010.0010.00[0.1 - 0.6]
cashFlowToDebtRatioTTM01.000-1.111-1.111[0.2 - 2]
assetTurnoverTTM0.1000.800-2.67-2.13[0.5 - 2]
Total Score7.79

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM10.551.0009.040[1 - 100]
returnOnEquityTTM0.08132.50-0.134-0.312[0.1 - 1.5]
freeCashFlowPerShareTTM0.09462.009.9710.00[0 - 30]
dividendYielPercentageTTM11.631.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM0.09462.009.9710.00[0 - 30]
payoutRatioTTM0.8281.5001.722-1.722[0 - 1]
pegRatioTTM1.4131.5003.920[0.5 - 2]
operatingCashFlowSalesRatioTTM0.9081.00010.000[0.1 - 0.5]
Total Score5.72

BioPharma Credit PLC Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

BioPharma Credit PLC

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company was incorporated in 2016 and is based in Exeter, the United Kingdom.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators